✦ LIBER ✦

The value of prognostic factors in selecting node-negative breast cancer patients for adjuvant therapy

✍ Scribed by Edward G. Mansour

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 284 KB
Volume: 49
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.2930490202

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognosis of a series of 763 consecutive

Prognosis of a series of 763 consecutive node-negative invasive breast cancer patients without adjuvant therapy: Analysis of clinicopathological prognostic factor

✍ Saimura, Michiyo; Fukutomi, Takashi; Tsuda, Hitoshi; Sato, Hiroshi; Miyamoto, Ka 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

## Background and Objectives: The objectives of this study were to confirm the favorable outcome of Japanese invasive breast cancer patients without lymph node metastasis, after treatment with surgery alone, and to evaluate clinicopathological prognostic factors in this population. Methods: The sub

Node negative breast cancer: The prognos

Node negative breast cancer: The prognostic value of DNA ploidy for long-term survival

✍ J. Yuan; C. Hennessy; I. P. Corbett; R. Dykin; A. L. Givan; B. K. Shenton; J. A. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 458 KB 👁 2 views

Possible tests for selection of adjuvant

Possible tests for selection of adjuvant systemic therapy in early cancer of the breast

✍ Timothy Cooke; W. D. George; K. Griffiths 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB 👁 2 views

Prognostic factors of early distant recu

Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy : Results of a retrospective analysis

✍ Marc Debled; Gaëtan MacGrogan; Véronique Brouste; Simone Mathoulin-Pelissier; Mi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 1 views

## Abstract ## BACKGROUND Current adjuvant hormone therapy in postmenopausal women with breast cancer is debatable between upfront aromatase inhibitors (AIs) and sequential treatment with tamoxifen. A major concern is the higher rate of early recurrences observed with sequential treatment. The aut

High expression of 90K (Mac-2 BP) is ass

High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies

✍ Nicola Tinari; Rossano Lattanzio; Patrizia Querzoli; Clara Natoli; Antonino Gras 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 234 KB

## Abstract 90K (Mac‐2 BP) expression was evaluated by immunohistochemistry in paraffin‐embedded tissue from a consecutive series of lymph‐node negative breast cancer patients who did not receive adjuvant systemic treatment. An independent series of patients served as validation set. The associatio

The prognostic value of p53 and c-erb b-

The prognostic value of p53 and c-erb b-2 immunostaining is overrated for patients with lymph node negative breast carcinoma : A multivariate analysis of prognostic factors in 613 patients with a follow-up of 14–30 years

✍ Wenche Reed; Einar Hannisdal; Per Johannes Boehler; Stein Gundersen; Herman Host 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

## BACKGROUND. Approximately 30% of breast carcinoma patients with negative lymph nodes die of their disease. Biologic markers such p53 protein and c-erb B-2 have been related to tumor progression, but their prognostic value remains controversial. ## METHODS. Two large series of a total of 613 ly